Hormonal insufficiency of the hypothalamic–pituitary–adrenal (HPA) axis is a common complication in patients who have undergone pituitary surgery. Different procedures are used to assess HPA function ...

Until now there has been no test that could detect synacthen, which when injected simulates the body to produce extra amounts of its own corticosteroid. This is most common in sports where sports ...

Injecting performance enhancing corticosteroid hormones for other than medical treatment is banned, and tests exist that can detect injected hormones. Injecting synacthen, which stimulates the body to ...

Questcor Pharmaceuticals said today it acquired rights to develop Synacthen® (tetracosactide) and Synacthen Depot in the U.S. from Novartis Pharma and parent company Novartis, in a deal that could net ...

This leaflet answers some common questions about Synacthen Depot. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

Scientists have found a way to detect use of a banned performance-enhancing drug by athletes for the first time. Sports cheats use the protein synacthen to stimulate the body to increase production of ...

The researchers estimate that the at-home test could reduce the number of Short Synacthen Tests undertaken for diagnosing adrenal insufficiency, from 92,000 per year to just 23,000 across England. The ...